Entries by

Home Page Slider Post #1

Glaucoma is the leading cause of irreversible blindness. The most successful way to prevent vision loss from glaucoma is to lower intraocular pressure with filtration surgery. This surgery shunts fluid out of the eye through a channel created during a trabeculectomy procedure or by a transscleral drainage device placed during Minimally Invasive Glaucoma Surgery (MIGS). […]

Home Page Featured Post #2

“For glaucoma surgery to be maximally successful, anti-scarring therapies must be effective, consistent in dosage as well as fast and very easy to administer. In combination with new glaucoma drainage devices, the RadianceTx Beta Ophthalmic Applicator System could revolutionize the treatment of glaucoma.”

RadianceTx Raises $1 Million First Tranche to Develop Novel Glaucoma Therapy

RadianceTx announced a $1 million first tranche closing of a targeted $7 million round of financing. The investment will be used to fund development of the company’s Beta Ophthalmic System for delivery of beta irradiation therapy to improve glaucoma surgery outcomes. Validated in three clinical studies conducted by preeminent ophthalmic research teams, beta therapy has […]